Turning Complexity into Clarity in AML: Using Small Group, Peer-focused Educational Experiences to Drive Best Practices

Jointly Provided by: Albert Einstein College of Medicine-Montefiore Medical Center and Medical Logix, LLC

3.50 AMA PRA Category 1 Credits™ and 3.50 ANCC contact hours

Credit Issued by: Albert Einstein College of Medicine-Montefiore Medical Center

Release Date: January 28, 2022                                                               

Expiration Date: January 28, 2023

Estimated time to complete this activity: 3.50 hours

Acknowledgement of Commercial Support: This educational activity is supported by an independent medical education grant from Bristol Myers Squibb.

Goal

The goal of this educational curriculum is to establish impactful small group interactions between members of the AML care team that will, through a variety of collaborative educational experiences, help participants improve their care practices and thereby improve the lives of patients with AML.

Statement of Need

Acute myeloid leukemia (AML) continues to be the most common acute leukemia in adults, with an incidence of 5.5 cases per 100,000 persons annually. Since the standard of care induction therapy for AML has largely remained the same for the past few decades and does not provide a cure for adults with AML, further treatment strategies are needed for this disease, both in the induction and maintenance of remission stages. In conversations with medical and hematologic oncologists, several key educational issues remain in the management of AML that this initiative will address, including use of induction therapy in the non-elderly population, treating suboptimal response to induction therapy, best practices for measurable (or minimal) residual disease assessment, and proper use of maintenance therapy. This collaborative social learning platform establishes a network of providers who can support each other locally, as well as those from different communities, with the goal of learning and sharing best practices that will improve outcomes for patients with AML.

Intended Audience

This educational activity is directed toward care providers of patients with AML, including physicians, NPs, PAs and nurses.

Learning Objectives

After participating in this activity, you will demonstrate the ability to:

• Use evidence-based practices to appropriately select combination treatments with hypomethylating agents in non-elderly patients with AML.
• Outline available evidence and current best practices in the treatment of patients with AML post-induction who have suboptimal response.
• Incorporate knowledge of currently available MRD testing methods to best assess residual disease in patients with AML.
• Apply knowledge of recent and emerging therapeutics for the maintenance treatment of AML.

ACCME Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and Medical Logix, LLC. Albert Einstein College of Medicine-Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.

Credit Designation Statement 

Physicians: Albert Einstein College of Medicine-Montefiore Medical Center designates this other (blended live and enduring curriculum) activity for a maximum of 3.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: The maximum number of hours awarded for this Continuing Nursing Education activity is 3.50 contact hours.

IPCE Credit: This activity was planned by and for the healthcare team, and learners will receive 3.50 Interprofessional Continuing Education (IPCE) credits for learning and change.

Format and Method of Participation

There is no fee to participate in this activity. You must review all activity information, including the learning objectives, disclosure statements and content.

To Obtain Credit:

To obtain credit, you must complete the components below, and the assessment and evaluation at the conclusion of the activity. A satisfactory score is defined as answering 80% of the post-assessment questions correctly. Your certificate can be printed immediately.

If you have questions about this CME activity, please contact Albert Einstein College of Medicine-Montefiore Medical Center at cme@montefiore.org.

• Baseline Assessment – Turning Complexity into Clarity in AML: Using Small Group, Peer-focused Educational Experiences to Drive Best Practices
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ANCC contact hour(s) 
• Self Study Module 1 – Background and Use of Hypomethylating Agents in AML
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 ANCC contact hour(s)
• Self Study Module 2 – Options After Suboptimal Response Chemotherapy: Case-Based Scenarios
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 ANCC contact hour(s)
• Self Study Module 3 – Measurable/Minimal Residual Disease (MRD) in AML Clinical Practice
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 ANCC contact hour(s)
• Self Study Module 4 – Maintenance Therapy in AML
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 ANCC contact hour(s)
• Final Assessment – Turning Complexity into Clarity in AML: Using Small Group, Peer-focused Educational Experiences to Drive Best Practices
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ANCC contact hour(s)
• Live Group Discussion #1: Key Insights on AML
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ANCC contact hour(s)
• Group Task
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ANCC contact hour(s)
• Live Group Discussion #2: AML Take-Home Messages: Putting the Evidence to Practice
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ANCC contact hour(s)

Conflict of Interest Statement

The “Policy on Collection of Relevant Financial Relationships and Resolution of COI” of Albert Einstein College of Medicine-Montefiore Medical Center requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company*. Albert Einstein College of Medicine-Montefiore Medical Center resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational activities. Any presenter whose disclosed relationships prove to create a conflict of interest with regard to their contribution to the activity will not be permitted to present. All relevant financial relationships and potential conflicts of interest have been mitigated prior to the activity.

Albert Einstein College of Medicine-Montefiore Medical Center also requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

*The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Course Director

Farhad Ravandi-Kashani, MD
Department of Leukemia, Division of Cancer Medicine
MD Anderson Cancer Center
Houston, TX

Disclosure: Consultant: AstraZeneca, BMS/Celgene, Syros, Taiho/Astex; Research Funding: Abbvie, Amgen, BMS/Celgene, Syros, Taiho/Astex, Xencor; Speaker: BMS/Celgene

Faculty

Nicole Chambers, FNP-BC
Nurse Practitioner
Hematology Oncology Department
Montefiore Medical Center
New York, NY

Disclosure: Nicole Chambers has no relevant conflicts of interest with any ACCME-defined ineligible company.

Education Planning Committee

Ioannis Mantzaris, MD, MS (Peer Reviewer)
Assistant Professor, Department of Medicine (Oncology)
Division of Bone Marrow Transplantation
Montefiore Einstein Center for Cancer Care
Bronx, NY

Disclosure: Ioannis Mantzaris has no relevant conflicts of interest with any ACCME-defined ineligible company.

Kathleen O’Connor, RN, BSN (Peer Reviewer)
Assistant Director, Office of Research and Sponsor Programs
Montefiore Medical Center
Bronx, NY

Disclosure: Kathleen O’Connor has no relevant conflicts of interest with any ACCME-defined ineligible company.

Victor B. Hatcher, PhD (CE Reviewer)
Associate Dean, Continuing Professional Development
Albert Einstein College of Medicine
Montefiore Medical Center
Bronx, NY

Disclosure: Victor B. Hatcher has no relevant conflicts of interest with any ACCME-defined ineligible company.

Medical Logix

John Gentile, Megan Gentile and Joshua Hwang, Medical Logix, LLC have indicated they do not have any relevant conflicts of interest with any ACCME-defined ineligible company.

Off-Label Discussion

This educational activity may contain discussion of the unlabeled/unapproved use of agents or classes. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Privacy Statement

Albert Einstein College of Medicine-Montefiore Medical Center, Center for Continuing Professional Development (Einstein-Montefiore) protects the privacy of personal and other information regarding participants and education collaborators. Einstein-Montefiore will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting to the ACCME.

Einstein-Montefiore maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse, or alteration of information collected from you.

Additional information regarding Albert Einstein College of Medicine-Montefiore Medical Center’s Privacy Policy can be viewed at https://www.mecme.org/PrivacyStatement.aspx 

Einstein-Montefiore is committed to protecting the privacy of personal information from our participants and educational collaborators. Einstein-Montefiore maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse, or alteration of personal information.

Collection and Use of Your Personal Information

The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing an activity. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of each activity. All evaluative information submitted is collected, retained, and used by Einstein-Montefiore to continuously improve the learning experience.

Einstein-Montefiore will not transfer, sell, or share personal information with outside parties or otherwise disclose personal information unless required to in a legal process. Einstein-Montefiore will retain your personal data only for the period necessary to accomplish the stated purposes and to comply with applicable laws.

© All rights reserved – Albert Einstein College of Medicine-Montefiore Medical Center and Medical Logix, LLC.